{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:53Z","timestamp":1761519053713,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.4158\/ep.12.4.406","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T21:04:54Z","timestamp":1365455094000},"page":"406-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Calciphylaxis in The Absence of End-Stage Renal Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Francesca M.","family":"Couto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc K.","family":"Drezner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.12.4.406_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1970.tb15697.x","article-title":"Cutaneous vascular calcification, gangrene and hyperparathyroidism","volume":"83","author":"Winkelmann","year":"1970","journal-title":"Br J Dermatol."},{"key":"10.4158\/EP.12.4.406_bb0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2230.2000.00671.x","article-title":"Calciphylaxis in the absence of renal failure","volume":"25","author":"Pollock","year":"2002","journal-title":"Clin Exp Dermatol."},{"key":"10.4158\/EP.12.4.406_bb0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0272-6386(97)90133-5","article-title":"Calciphylaxis in a patient with Crohn\u2019s disease in the absence of end-stage renal disease","volume":"29","author":"Barri","year":"1997","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.12.4.406_bb0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2133.2000.03853.x","article-title":"Calciphylaxis without renal failure or elevated parathyroid hormone: possible aetiological role of chemotherapy","volume":"143","author":"Goyal","year":"2000","journal-title":"Br J Dermatol."},{"issue":"2 Pt 2","key":"10.4158\/EP.12.4.406_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0190-9622(99)70368-3","article-title":"Calciphylaxis associated with metastatic breast carcinoma","volume":"41","author":"Mastruserio","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"10.4158\/EP.12.4.406_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archderm.1996.03890310129026","article-title":"Calciphylaxis without renal failure [letter]","volume":"132","author":"Fader","year":"1996","journal-title":"Arch Dermatol."},{"key":"10.4158\/EP.12.4.406_bb0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s100670200016","article-title":"Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: the possible role of long-term steroid use and protein S deficiency","volume":"21","author":"Korkmaz","year":"2002","journal-title":"Clin Rheumatol."},{"key":"10.4158\/EP.12.4.406_bb0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4065\/76.7.749","article-title":"Calciphy-laxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K","volume":"76","author":"Riegert-Johnson","year":"2001","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.12.4.406_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<289::AID-MUS24>3.0.CO;2-H","article-title":"Rhabdomyolysis as the presenting manifestation of calciphylaxis","volume":"23","author":"Randall","year":"2000","journal-title":"Muscle Nerve."},{"key":"10.4158\/EP.12.4.406_bb0050","doi-asserted-by":"crossref","first-page":"E686","DOI":"10.1152\/ajpendo.00552.2003","article-title":"Osteogenic regulation of vascular calcification: an early perspective","volume":"286","author":"Vattikuti","year":"2004","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"10.4158\/EP.12.4.406_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature."},{"key":"10.4158\/EP.12.4.406_bb0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a sys-temically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer","year":"2003","journal-title":"J Clin Invest."},{"key":"10.4158\/EP.12.4.406_bb0065","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/0190-9622(95)90286-4","article-title":"Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic failure and benefit from parathyroidectomy","volume":"33","author":"Hafner","year":"1995","journal-title":"J Am Acad Dermatol."},{"key":"10.4158\/EP.12.4.406_bb0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/msy.2001.117101","article-title":"Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism [with discussion]","volume":"130","author":"Girotto","year":"2001","journal-title":"Surgery."},{"key":"10.4158\/EP.12.4.406_bb0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","article-title":"Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment","volume":"15","author":"Wilmer","year":"2002","journal-title":"Semin Dial."},{"year":"1962","series-title":"Calciphylaxis","author":"Selye","key":"10.4158\/EP.12.4.406_bb0080"},{"key":"10.4158\/EP.12.4.406_bb0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00223-002-1006-9","article-title":"The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption","volume":"71","author":"Price","year":"2002","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP.12.4.406_bb0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5414\/CNP59463","article-title":"A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies","volume":"59","author":"Don","year":"2003","journal-title":"Clin Nephrol."},{"key":"10.4158\/EP.12.4.406_bb0095","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","article-title":"Risk factors and mortality associated with calciphylaxis in end-stage renal disease","volume":"60","author":"Mazhar","year":"2001","journal-title":"Kidney Int."},{"key":"10.4158\/EP.12.4.406_bb0100","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int."},{"key":"10.4158\/EP.12.4.406_bb0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/ajkd.1998.v32.pm9740152","article-title":"A case control study of proximal calciphylaxis","volume":"32","author":"Bleyer","year":"1998","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.12.4.406_bb0110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.62.5.407","article-title":"Diagnostic strategy for the assessment of rheumatoid vasculitis","volume":"62","author":"Voskuyl","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.4158\/EP.12.4.406_bb0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9343(90)90150-C","article-title":"Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis","volume":"88","author":"Mehta","year":"1990","journal-title":"Am J Med."},{"key":"10.4158\/EP.12.4.406_bb0120","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/oxfordjournals.ndt.a027686","article-title":"Calciphylaxis in a haemodialysis patient: functional protein S deficiency?","volume":"11","author":"Perez-Mijares","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP.12.4.406_bb0125","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1210\/jc.2003-031979","article-title":"Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization","volume":"89","author":"Binkley","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.4.406_bb0130","first-page":"676","article-title":"Hyperbaric oxygen therapy for calcific ure-mic arteriolopathy: a case series","volume":"15","author":"Basile","year":"2002","journal-title":"J Nephrol."},{"key":"10.4158\/EP.12.4.406_bb0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1067\/msy.2000.110429","article-title":"Is calciphylaxis best treated surgically or medically [with discussion]?","volume":"128","author":"Kang","year":"2000","journal-title":"Surgery."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/BDFKRY6NLM1WQ85M.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:46:43Z","timestamp":1761515203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20418105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1530891X20418105"],"URL":"https:\/\/doi.org\/10.4158\/ep.12.4.406","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calciphylaxis in The Absence of End-Stage Renal Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.12.4.406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}